These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Expression of Forkhead Box P3 T Regulatory Lymphocytes as a Prognostic Factor in Malignant Melanomas. Gâta VA; Pașca A; Roman A; Muntean MV; Morariu DȘ; Bonci EA; Dina C; Ungureanu L Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928083 [TBL] [Abstract][Full Text] [Related]
3. Regulatory T cells, especially ICOS Tu JF; Ding YH; Ying XH; Wu FZ; Zhou XM; Zhang DK; Zou H; Ji JS Sci Rep; 2016 Oct; 6():35056. PubMed ID: 27725696 [TBL] [Abstract][Full Text] [Related]
4. Cancerous HLA class I expression and regulatory T cell infiltration in gastric cancer. Ishigami S; Arigami T; Uenosono Y; Matsumoto M; Okumura H; Uchikado Y; Kita Y; Nishizono Y; Maemura K; Kijima Y; Nakajo A; Owaki T; Ueno S; Hokita S; Natsugoe S Cancer Immunol Immunother; 2012 Oct; 61(10):1663-9. PubMed ID: 22374482 [TBL] [Abstract][Full Text] [Related]
5. Transcriptional switches in melanoma T Cells: Facilitating polarizing into regulatory T cells. Li T; Wu T; Li X; Qian C Int Immunopharmacol; 2024 Aug; 137():112484. PubMed ID: 38885605 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the MT-2 Treg-like cell line in the presence and absence of forkhead box P3 (FOXP3). McCullough MJ; Tune MK; Cabrera JC; Torres-Castillo J; He M; Feng Y; Doerschuk CM; Dang H; Beltran AS; Hagan RS; Mock JR Immunol Cell Biol; 2024 Mar; 102(3):211-224. PubMed ID: 38288547 [TBL] [Abstract][Full Text] [Related]
7. The prognostic value of Forkhead box P3 regulatory T cells in biliary tract cancer: A systematic review and meta-analysis. Cai P; Wu Z; Yang X; Wang N; Yang Y Medicine (Baltimore); 2023 Dec; 102(50):e36608. PubMed ID: 38115302 [TBL] [Abstract][Full Text] [Related]
8. A Metabolic Gene Survey Pinpoints Fucosylation as a Key Pathway Underlying the Suppressive Function of Regulatory T Cells in Cancer. Pinioti S; Sharma H; Flerin NC; Yu Q; Tzoumpa A; Trusso Cafarello S; De Bousser E; Callewaert N; Oldenhove G; Schlenner S; Thienpont B; Garg AD; Di Matteo M; Mazzone M Cancer Immunol Res; 2023 Dec; 11(12):1611-1629. PubMed ID: 37933083 [TBL] [Abstract][Full Text] [Related]
9. Prognostic value of FOXP3 Bai Y; He T; Zhang L; Liu Q; Yang J; Zhao Z; Yang K; Zhang M BMJ Open; 2022 Sep; 12(9):e060659. PubMed ID: 36691128 [TBL] [Abstract][Full Text] [Related]
10. FOXP3 (in)stability and cancer immunotherapy. Mortezaee K Cytokine; 2024 Jun; 178():156589. PubMed ID: 38547750 [TBL] [Abstract][Full Text] [Related]
11. FOXP3 in Melanoma with Regression: Between Tumoral Expression and Regulatory T Cell Upregulation. Cioplea M; Nichita L; Georgescu D; Sticlaru L; Cioroianu A; Nedelcu R; Turcu G; Rauta A; Mogodici C; Zurac S; Popp C J Immunol Res; 2020; 2020():5416843. PubMed ID: 33274240 [TBL] [Abstract][Full Text] [Related]
12. Frequency of infiltrating regulatory T-cells in the portal tract of biliary atresia. Oita S; Saito T; Hashimoto R; Fumita T; Katsumata Y; Terui K; Komatsu S; Takenouchi A; Ikeda JI; Hishiki T Pediatr Surg Int; 2023 Sep; 39(1):259. PubMed ID: 37656274 [TBL] [Abstract][Full Text] [Related]
13. Role of regulatory T cells in mouse lung development. Jiang JF; Lu HY; Wang MY; He LY; Zhu Y; Qiao Y Exp Biol Med (Maywood); 2024; 249():10040. PubMed ID: 38577707 [TBL] [Abstract][Full Text] [Related]
14. Regulatory T-cell heterogeneity and the cancer immune response. Ward-Hartstonge KA; Kemp RA Clin Transl Immunology; 2017 Sep; 6(9):e154. PubMed ID: 28983402 [TBL] [Abstract][Full Text] [Related]
15. Regulatory T-cell-mediated inhibition of antitumor immune responses is associated with clinical outcome in patients with liver metastasis from colorectal cancer. Brudvik KW; Henjum K; Aandahl EM; Bjørnbeth BA; Taskén K Cancer Immunol Immunother; 2012 Jul; 61(7):1045-53. PubMed ID: 22159472 [TBL] [Abstract][Full Text] [Related]
16. Regulatory T cells in colorectal cancer patients suppress anti-tumor immune activity in a COX-2 dependent manner. Yaqub S; Henjum K; Mahic M; Jahnsen FL; Aandahl EM; Bjørnbeth BA; Taskén K Cancer Immunol Immunother; 2008 Jun; 57(6):813-21. PubMed ID: 17962941 [TBL] [Abstract][Full Text] [Related]
17. Divergent local and systemic antitumor response in primary uveal melanomas. Lucibello F; Lalanne AI; Le Gac AL; Soumare A; Aflaki S; Cyrta J; Dubreuil L; Mestdagh M; Salou M; Houy A; Ekwegbara C; Jamet C; Gardrat S; Le Ven A; Bernardeau K; Cassoux N; Matet A; Malaise D; Pierron G; Piperno-Neumann S; Stern MH; Rodrigues M; Lantz O J Exp Med; 2024 Jun; 221(6):. PubMed ID: 38563818 [TBL] [Abstract][Full Text] [Related]
18. Basic principles of tumor-associated regulatory T cell biology. Savage PA; Malchow S; Leventhal DS Trends Immunol; 2013 Jan; 34(1):33-40. PubMed ID: 22999714 [TBL] [Abstract][Full Text] [Related]
19. Regulatory T-Cells and Multiple Myeloma: Implications in Tumor Immune Biology and Treatment. Hadjiaggelidou C; Katodritou E J Clin Med; 2021 Oct; 10(19):. PubMed ID: 34640606 [TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells in colorectal cancer: from biology to prognostic relevance. Mougiakakos D Cancers (Basel); 2011 Mar; 3(2):1708-31. PubMed ID: 24212779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]